- September 7, 2019
- 10:00 am to 11:30 am
- Online Session with Dr. Cathy Coleman, mentors and graduates
At least 1 hour prior to this online session, please use our quick two-step RSVP and registration process:
1) RSVP in advance of the meeting. Then next, go to step 2) ....
2) Pre-register with Zoom. You will receive an email with instructions on how to join the session.
Find out how to be part of the next cohort of CIIS' groundbreaking Certificate in Psychedelic-Assisted Therapies & Research!
Meet Dr. Cathy Coleman, teachers, and several graduates of the Center for Psychedelic Therapies and Research and learn what this professional certificate program is all about. Ask questions after a presentation on the format of the training program. Hear why we designed the certificate, how you will benefit from it, and how you can be a part of the long-term vision. Learn how the certificate program can advance your progress toward your professional goals. Hear details about the choice of the Boston, San Francisco, or Online-only cohort.
About the Program
The Psychedelic-Assisted Therapies and Research Certificate Program serves a growing need for the training of skilled therapist researchers who will ideally seek advanced training for future FDA-approved psychedelic-assisted and entactogen-assisted psychotherapy research, as well as therapeutic work during expanded access clinic research programs. Enrollees are from specific licensed professions in mental health and medicine.
For more information, download the program and application 2022 Information Packet.
For all cohorts, the 2022 curriculum entails 150 total hours of instruction, including 120 hours of in-class learning (online and/or in-person) and 30 hours of individualized learning, mentor consultations, and online video instruction. Applicants will choose their preferred cohort at time of application: San Francisco, Boston, or Online-only.
The Online-only cohort will participate in the Boston class dates virtually for the training weekends. The San Francisco program is hybrid only. All applicants commit to the timing and type of the cohort to which they are admitted.
Hybrid Online and Residential Format for the Boston and San Francisco Cohorts
For both the Boston and San Francisco based cohorts, the certificate program course schedule will be comprised of six total weekends; two 4-day in-person weekends, a 6-day in-person training, and three 2-day online weekends.
One spring 2022 weekend will be in-person in order to experience Holotropic Breathwork during part of that course meeting. There will be a 6-day in-person training in the summer, and the final meeting in the fall will also be held in-person. The in-person weekends will be conducted at a comfortable conference hotel.
We are excited to offer an Online-only cohort beginning in 2022. We have limited the composition of this cohort to licensed psychotherapists, psychiatrists, and psychiatric nurses. These licensed professionals have the necessary and sufficient supervised clinical and psychotherapeutic background in order to complete the required role-plays online.
In 2023, we may allow other professionals to join the Online-only cohort, but for 2022 this cohort is limited to these specific professional groups (see below for specific professions eligible for this cohort).
As with the hybrid cohorts, the Online-only cohort includes 6 total weekends, all conducted virtually via Zoom. The two 4-day weekends and the 6-day training will include the Boston hybrid cohort trainees, and three 2-day weekends will be held with both 2022 hybrid classes. Online trainees will be supported by teaching assistants and will participate at a distance, doing the experiential learning modules via video conference break-out rooms.
For questions about registering for the Info Session, contact a member of the team at adminCPTR@ciis.edu.
CIIS Center for Psychedelic Therapies and Research
1453 Mission Street
San Francisco, CA 94103
Phone: (415) 575-6243
We are an academic program, and we are not able to provide therapist referrals at this time.